Novel compounds of the formula (I) in which D, E, Q, T, X, Y, Z, Z′, R
1
, R
4
and R
4′
have the meanings indicated in patent Claim
1
, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours
公式(I)中的化合物,其中D,E,Q,T,X,Y,Z,Z',R1,R4和R4'具有专利权要求书中指示的含义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓栓塞性疾病和肿瘤的治疗。